The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

According to the CDC, Vermont is among the states with the highest rates of new hepatitis C infections ... The first step is testing. Primary care providers can perform tests.

The Regional District of Central Kootenay in British Columbia says it will ask the Canadian Food Inspection Agency to conduct further testing for avian flu on a flock of ostriches facing a cull ...

The Regional District of Central Kootenay in British Columbia says it will ask the Canadian Food Inspection Agency to conduct further testing for avian flu on a ... a director for the area that ...

The Regional District of Central Kootenay in British Columbia says it will ask the Canadian Food Inspection Agency to conduct further testing for ... includes Edgewood, B.C., where Universal ...

Sixty-four more hospitals had a rate of zero, the lowest rate possible, for C. diff infections compared to CMS’ 2023 list.

Telangana and Andhra Pradesh police arrested two individuals, Sameer from Hyderabad and Siraj Ur Rehman from Vizianagaram. They were allegedly planning bomb blasts. Siraj procured bomb-making ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

The initial testing will go as follows: DATCP will provide updates on the NMTS collection process as the program develops. Residents are encouraged to visit the DATCP website for additional resources.